NORTH BRUNSWICK, N.J.--(BUSINESS WIRE)--Advaxis, Inc., (OTCBB: ADXS), the live, attenuated Listeria monocytogenes (Lm) immunotherapy company, invites common stock shareholders and other interested parties to the 2010 Advaxis Annual General Meeting of shareholders (AGM).
